99 related articles for article (PubMed ID: 21317540)
1. Interpretation of the effects of protein kinase C inhibitors on human UDP-glucuronosyltransferase 1A (UGT1A) proteins in cellulo.
Abe Y; Fujiwara R; Oda S; Yokoi T; Nakajima M
Drug Metab Pharmacokinet; 2011 Jun; 26(3):256-65. PubMed ID: 21317540
[TBL] [Abstract][Full Text] [Related]
2. Regulation of uridine diphosphate-glucuronosyltransferase 1A3 activity by protein phosphorylation.
Xiao Y; Yao Y; Jiang H; Lu C; Zeng S; Yu L
Biopharm Drug Dispos; 2015 Nov; 36(8):520-8. PubMed ID: 26094731
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity.
Basu NK; Kovarova M; Garza A; Kubota S; Saha T; Mitra PS; Banerjee R; Rivera J; Owens IS
Proc Natl Acad Sci U S A; 2005 May; 102(18):6285-90. PubMed ID: 15845768
[TBL] [Abstract][Full Text] [Related]
4. The major chemical-detoxifying system of UDP-glucuronosyltransferases requires regulated phosphorylation supported by protein kinase C.
Basu NK; Kole L; Basu M; Chakraborty K; Mitra PS; Owens IS
J Biol Chem; 2008 Aug; 283(34):23048-61. PubMed ID: 18556656
[TBL] [Abstract][Full Text] [Related]
5. Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase (UGT1A1) activity.
Basu NK; Kole L; Owens IS
Biochem Biophys Res Commun; 2003 Mar; 303(1):98-104. PubMed ID: 12646172
[TBL] [Abstract][Full Text] [Related]
6. Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6.
Volak LP; Court MH
Xenobiotica; 2010 May; 40(5):306-18. PubMed ID: 20196639
[TBL] [Abstract][Full Text] [Related]
7. Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.
Zhang H; Patana AS; Mackenzie PI; Ikushiro S; Goldman A; Finel M
Drug Metab Dispos; 2012 Oct; 40(10):1935-44. PubMed ID: 22782802
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach.
Papageorgiou I; Court MH
Biochem Pharmacol; 2017 Aug; 137():93-106. PubMed ID: 28433553
[TBL] [Abstract][Full Text] [Related]
9. miR-141-3p commonly regulates human UGT1A isoforms via different mechanisms.
Tatsumi N; Tokumitsu S; Nakano M; Fukami T; Nakajima M
Drug Metab Pharmacokinet; 2018 Aug; 33(4):203-210. PubMed ID: 30001838
[TBL] [Abstract][Full Text] [Related]
10. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
11. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of human UDP-glucuronosyltransferase genes.
Hu DG; Meech R; McKinnon RA; Mackenzie PI
Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of glucuronidation markedly improves drug efficacy in mice - a model.
Basu NK; Kole L; Basu M; McDonagh AF; Owens IS
Biochem Biophys Res Commun; 2007 Aug; 360(1):7-13. PubMed ID: 17586469
[TBL] [Abstract][Full Text] [Related]
14. An investigation of human and rat liver microsomal mycophenolic acid glucuronidation: evidence for a principal role of UGT1A enzymes and species differences in UGT1A specificity.
Miles KK; Stern ST; Smith PC; Kessler FK; Ali S; Ritter JK
Drug Metab Dispos; 2005 Oct; 33(10):1513-20. PubMed ID: 16033946
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T
Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
[TBL] [Abstract][Full Text] [Related]
17. ATP serves as an endogenous inhibitor of UDP-glucuronosyltransferase (UGT): a new insight into the latency of UGT.
Ishii Y; An K; Nishimura Y; Yamada H
Drug Metab Dispos; 2012 Nov; 40(11):2081-9. PubMed ID: 22851616
[TBL] [Abstract][Full Text] [Related]
18. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.
Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M
Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920
[TBL] [Abstract][Full Text] [Related]
19. Backbone assignment of the apo-form of the human C-terminal domain of UDP-glucuronosyltransferase 1A (UGT1A).
Osborne MJ; Coutinho de Oliveira L; Volpon L; Borden KLB
Biomol NMR Assign; 2018 Oct; 12(2):315-318. PubMed ID: 29934866
[TBL] [Abstract][Full Text] [Related]
20. Medicinal Chemistry and NMR Driven Discovery of Novel UDP-glucuronosyltransferase 1A Inhibitors That Overcome Therapeutic Resistance in Cells.
Osborne MJ; Sulekha A; Culjkovic-Kraljacic B; Gasiorek J; Ruediger E; Jolicouer E; Marinier A; Assouline S; Borden KLB
J Mol Biol; 2024 Jan; 436(2):168378. PubMed ID: 38043731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
